Search research articles
Contact Us
Filters
Showing results (101-110 of 159) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 6, 2019
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Roisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2026
Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanoma
George Ansstas, Karam Khaddour, Sumedha Sudhaman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 2, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
Neil Carleton, Alexander C Chang, Fangyuan Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
Costanza Paoletti, Yufeng Li, Maria C Muñiz, et al.
Annals of Surgery
|
September 26, 2025
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study
Koji Ando, Atsushi Hamabe, Yoshiaki Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2013
Developing safety criteria for introducing new agents into neoadjuvant trials
Angela DeMichele, Donald A Berry, JoAnne Zujewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2013
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer
Ayca Gucalp, Sara Tolaney, Steven J Isakoff, et al.
NAR Cancer
|
June 23, 2022
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
Kevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, et al.
Journal of Translational Medicine
|
July 4, 2012
Considerations in the development of circulating tumor cell technology for clinical use
David R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, et al.
European Urology Oncology
|
July 16, 2024
Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer
John P Sfakianos, Arnab Basu, George Laliotis, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 159) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 6, 2019
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Roisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2026
Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanoma
George Ansstas, Karam Khaddour, Sumedha Sudhaman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 2, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
Neil Carleton, Alexander C Chang, Fangyuan Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
Costanza Paoletti, Yufeng Li, Maria C Muñiz, et al.
Annals of Surgery
|
September 26, 2025
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study
Koji Ando, Atsushi Hamabe, Yoshiaki Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2013
Developing safety criteria for introducing new agents into neoadjuvant trials
Angela DeMichele, Donald A Berry, JoAnne Zujewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2013
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer
Ayca Gucalp, Sara Tolaney, Steven J Isakoff, et al.
NAR Cancer
|
June 23, 2022
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
Kevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, et al.
Journal of Translational Medicine
|
July 4, 2012
Considerations in the development of circulating tumor cell technology for clinical use
David R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, et al.
European Urology Oncology
|
July 16, 2024
Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer
John P Sfakianos, Arnab Basu, George Laliotis, et al.
Page
of 16